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cataracts, diabetic retinopathy, age-related macular
degeneration and cytomegalovirus retinitis. CONCLU-
SIONS: For research that requires a self-administered
measure of vision-related QOL, the NEI-VFQ-25 appears
to be the optimum choice. It has demonstrated accept-
able psychometric properties across several QOL
domains with minimal respondent burden.
PES13
COMPARING THE QUALITY OF LIFE EFFECTS
OF PRIMARY FOCAL HYPERHIDROSIS TO
OTHER DERMATOLOGICAL CONDITIONS AS
ASSESSED BY THE DERMATOLOGY LIFE
QUALITY INDEX (DLQI)
Naumann M1, Hamm H1, Spalding JR2, Kowalski J3, Lee J3
1University of Würzburg, Würzburg, Germany; 2University of
Southern California, Los Angeles, CA, USA; 3Allergan, Irvine,
CA, USA
OBJECTIVES: The objective of this study was to assess
and descriptively compare the quality of life (QOL)
effects of hyperhidrosis (HH), as measured by the Der-
matology Life Quality Index (DLQI), relative to other
dermatological conditions with published DLQI scores.
METHODS: Primary hyperhidrosis patients asking for
care at the Dermatology Clinic of the University of
Würzburg completed the DLQI as part of a research study
to assess the quality of life burden resulting from 
hyperhidrosis. Patients were categorized by main site of
involvement (i.e. axillary, palmar, other) to identify any
focal location-dependent differences. In addition, a liter-
ature search was performed to identify published reports
of DLQI scores for hyperhidrosis and other dermatolog-
ical conditions. Mean DLQI total scores observed in this
clinic cohort were compared with those for other derma-
tological conditions to determine the relative QOL effects
of hyperhidrosis. RESULTS: DLQI data were collected
from 345 hyperhidrosis patients in the dermatology
clinic. Forty-two published reports of mean DLQI total
scores for dermatological conditions, including three for
hyperhidrosis, were identiﬁed. Mean DLQI total scores
for hyperhidrosis ranged from 9.9–18 indicating signiﬁ-
cant quality of life impairment. By focal location of
hyperhidrosis, reported ranges for mean DLQI total
scores were: palmar (8.8–18), axillary (10–17), facial
(12.5), and mixed (9.2–15.5). Overall, hyperhidrosis was
associated with similar or greater impairment than other
dermatological conditions including psoriasis (4.5–13.9),
eczema (4.1–16.2), and acne (4.3–9.3). Similar mean
DLQI total scores and ranges were observed for both axil-
lary and palmar hyperhidrosis. CONCLUSIONS: This
review suggests that the QOL effects of hyperhidrosis as
assessed by the DLQI are comparable to, and in most
cases greater than, other dermatological conditions for
which DLQI data are available.
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OBJECTIVES: Quality of life enables patients to assess
the different consequences of the disease and/or treat-
ment. Skin disorders have a strong impact on the patient’s
physical and psychological well-being and the numerous
quality of life studies carried out among adults are here
to conﬁrm this. However, very few studies have been 
performed to assess the quality of life in children. This 
is mainly attributable to the fact that there is a lack of 
questionnaires to do this. METHOD: A speciﬁc scale
developed by Professor A. FINLAY (C-DLQI—Children-
Dermatology Life Quality Index) is completed by each
child before starting the course of treatment at Avène
Hydrotherapy Center, after three weeks of treatment,
after three months and after 6 months. RESULTS: Every
year, Avène Hydrotherapy Center welcomes a growing
number of children suffering from chronic dermatosis. It
thus seemed relevant to assess the quality of life of these
children (4–15 years old). The following initial analysis
has been obtained from the 30 ﬁrst questionnaires 
completed upon inclusion and after 3 months. The DLQI
score upon inclusion was 23.58 and 11.60 after 3
months. The results show an improvement in the patient’s
quality of life 3 months after the hydrotherapy course 
of treatment. This difference is statistically signiﬁcant 
(p = 0.010). After 3 weeks of treatment, the C-DLQI score
was 20.3 (p = 20.32). CONCLUSION: These results
clearly show that even some time after the end of the
hydrotherapy course of treatment, quality of life in chil-
dren suffering from chronic dermatosis continues to be
improved.
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OBJECTIVE: The objective of our work was to translate
the Cardiff Acne Disability Index (CADI) into French,
with careful attention to the linguistic aspects and the 
cultural context of the French patients. METHOD: The
CADI is a scale devised by Prof. R.J. Motley and A. Finlay
of Cardiff to assess the disability caused by acne. This
questionnaire has been used in numerous studies to eval-
uate the consequences of the disease in daily life or the
effects of different treatments. Following international
methodological recommendations, the CADI scale was
translated in a standardized way consisting of forward
translation, quality control, backward translation, and a
